Omnicell, Inc. (NASDAQ: OMCL) develops healthcare technology for autonomous medication management across pharmacy and nursing care settings. Its updates cover financial results, product bookings, recurring revenue, connected-device demand, and product launches such as Omnicell Titan XT and the OmniSphere platform.
Company news also includes healthcare conference presentations, customer engagement programs, clinical leadership roles, and innovation updates tied to automation, AI-enabled intelligence, software workflows, data analytics, and expert services for medication management in healthcare facilities.
Omnicell, Inc. (NASDAQ:OMCL) will host a conference call on October 27, 2020, at 1:30 p.m. PT to discuss its Third Quarter 2020 financial results. The call will feature Randall Lipps, the company’s CEO, and Peter Kuipers, CFO. Interested parties can participate by calling 1-800-696-5518 in the U.S. or 1-706-758-4883 internationally. A webcast will also be available on Omnicell’s investor relations website. A replay will be accessible from October 27, 2020, at 4:30 p.m. PT through November 24, 2020.